What Management Is There for Gonorrhea in the Postquinolone Era?
- 1 January 2006
- journal article
- editorial
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 33 (1), 8-10
- https://doi.org/10.1097/01.olq.0000194599.97426.a3
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Increase of Neisseria gonorrhoeae Ciprofloxacin Resistance in France in 2001–2003Sexually Transmitted Diseases, 2006
- Prevalence of and Associated Risk Factors for Fluoroquinolone-Resistant Neisseria gonorrhoeae in California, 2000-2003Clinical Infectious Diseases, 2005
- Antibiotic Resistance inNeisseria gonorrhoeaeClinical Infectious Diseases, 2005
- Fluoroquinolone Resistance Among Neisseria gonorrhoeae Isolates in Hawaii, 1990–2000Sexually Transmitted Diseases, 2004
- The use of fluoroquinolones in gonorrhoea: the increasing problem of resistanceExpert Opinion on Pharmacotherapy, 2004
- Outbreak of Cefozopran (Penicillin, Oral Cephems, and Aztreonam)-Resistant Neisseria gonorrhoeae in JapanAntimicrobial Agents and Chemotherapy, 2001
- Correlation of In Vitro Susceptibilities to Newer Quinolones of Naturally Occurring Quinolone-Resistant Neisseria gonorrhoeae Strains with Changes in GyrA and ParCAntimicrobial Agents and Chemotherapy, 2001
- Failure of Azithromycin Therapy in Gonorrhea and Discorrelation With Laboratory Test ParametersSexually Transmitted Diseases, 1998
- Ethnicity and sexually transmitted infectionsCurrent Opinion in Infectious Diseases, 1998
- Effect of Spectinomycin Use on the Prevalence of Spectinomycin-Resistant and of Penicillinase-ProducingNeisseria GonorrhoeaeNew England Journal of Medicine, 1987